Skip to main contentSkip to privacy choices

Case Studies & Evidence

Evidence for consequential decisions

Explore how IG-Smart helps organisations improve governance, privacy, cyber assurance and decision-making in regulated and high-consequence environments.

  • Named & anonymised evidence

    Real engagements with confidentiality protected

  • Client validation

    Published evidence and testimonials

  • Decision-ready outputs

    Practical, accountable and board-ready

  • Regulated & high-consequence environments

    Experience across complex regulated sectors

Evidence library

Matching case studies

International privacy evidence: AIMIA, Glenmark and a US-headquartered pharmaceutical business.

4 matching case studies · 34 total

  • Conceptual illustration: scientist using a microscope in a pharmaceutical laboratory; blue and orange contour treatment.Glenmark Pharmaceuticals logo

    Life Sciences & Pharmaceuticals, Named client

    Glenmark Pharmaceuticals

    Retained external DPO service for a global pharmaceutical company

    Evidence available:

    • Named executive testimonial
    • Engagement scope stated
    • Deliverables described

    What IG-Smart did · Data Privacy & DPO

    IG-Smart provides a retained external Data Protection Officer service to Glenmark Pharmaceuticals, advising its legal and compliance teams on privacy matters under a global remit.

    What this demonstrates

    Relevant to multinational regulated organisations that need responsive external DPO capability across multiple jurisdictions without building equivalent permanent capability in-house.

    “Knowledgeable and responsive… IG help us to navigate an otherwise tricky area of compliance.”
    Oliver Bourne, Vice President, Legal and Compliance – EU and LATAM, Glenmark Global Pharmaceuticals

    Delivery:Manage

    Read the full case study: Glenmark Pharmaceuticals
  • Conceptual artwork representing international data-transfer governance for an anonymised global pharmaceutical engagement.Client identity withheld

    Life Sciences & Pharmaceuticals, Anonymised engagement

    A US-headquartered global pharmaceutical company with international operations

    Harmonising international data transfers for a global pharmaceutical company

    Evidence available:

    • Engagement scope stated
    • Deliverables described

    What IG-Smart did · Data Privacy & DPO

    IG-Smart helped a US-headquartered global pharmaceutical company build a documented cross-border data-transfer framework, using Standard Contractual Clauses, transfer impact assessments and practical SOPs for IT and compliance teams.

    What this demonstrates

    Relevant to multinational regulated organisations that need defensible international data-transfer governance across differing legal regimes, supported by workable transfer mechanisms, assessments and operating procedures.

    Read the full case study: A US-headquartered global pharmaceutical company with international operations
  • Conceptual architectural artwork representing university information governance for the UCL case study.UCL logo

    NHS, Health & HealthTech, Named client

    UCL

    Information-governance audit and DSPT readiness for a leading research university

    Evidence available:

    • Named executive testimonial
    • Engagement scope stated
    • Deliverables described

    What IG-Smart did · Information Governance

    IG-Smart audited information-governance policies and procedures in UCL's School of Life and Medical Sciences, produced a prioritised improvement plan for DSPT readiness, and was retained for leadership training and an ISO/IEC 27001-referenced physical-security audit.

    What this demonstrates

    Relevant to research, healthcare and other regulated organisations that need an independent assessment of information-governance readiness, clear remediation priorities and evidence capable of supporting an NHS DSPT submission.

    “The report provided insight that helped shape and focus our final DSP Toolkit submission.”
    Trevor Peacock, Head of Information Governance, UCL
    Read the full case study: UCL
  • Conceptual illustration: researchers in a daylit biomedical laboratory reviewing shared research dataNational Institute for Health and Care Research logo

    NHS, Health & HealthTech, Named client

    National Institute for Health and Care Research (NIHR)

    Information governance framework for national patient-data sharing across the UK's original Biomedical Research Centres

    Evidence available:

    • Engagement scope stated
    • Deliverables described

    What IG-Smart did · Information Governance

    IG-Smart developed the information governance framework that enabled the National Institute for Health Research's Health Informatics Collaborative to share complex, voluminous patient datasets for research across the UK's five original national Biomedical Research Centres — Oxford, Cambridge, Guy's, King's and UCLH.

    What this demonstrates

    Relevant to research consortia, NHS and academic partnerships, trusted research environments and data platforms that need lawful, trusted data-sharing frameworks.

    Delivery:AssessBuildAssure

    Read the full case study: National Institute for Health and Care Research (NIHR)

Client voices

Client voices behind the evidence

IG Smart have provided us with quality subject matter experts surrounding GDPR and Privacy risk-based analysis and remediation; supplying qualified senior information security and experienced DPO and specialists.

Dan WestGlobal CIO, AIMIA ILS

Integrated privacy and information-security expertise

View the evidence — AIMIA ILS case study

What the evidence helps clients decide

Decision-ready outputs

The outlines show how IG-Smart structures typical outputs. They are not client documents.

  • Prioritise remediation

    Independent audit report · Supplier, IG or security audit

    An independent view of how controls operate in practice, with rated findings and recommendations.

    Used by:
    Risk, compliance and procurement leads; supplier owners
    Supports:
    Supplier assurance, remediation and contract decisions
    View typical structure

    Representative IG-Smart structure — client information not shown

    1. 01Scope and method
    2. 02Findings by control area
    3. 03Risk rating and rationale
    4. 04Prioritised recommendations
    5. 05Residual risk and owner
  • Plan and evidence improvement

    Prioritised improvement plan · Readiness for DSPT, ISO/IEC 27001 or audit

    A sequenced plan that turns gaps into owned, evidenced actions.

    Used by:
    Programme owners, SIROs, IG and security leads
    Supports:
    Resourcing, sequencing and readiness decisions
    View typical structure

    Representative IG-Smart structure — client information not shown

    1. 01Current-state gaps
    2. 02Priority and dependency
    3. 03Owner and timescale
    4. 04Evidence required
    5. 05Progress tracking
  • Maintain accountability

    Retained DPO advisory record · Outsourced or fractional DPO service

    A running record of matters raised, advice given and the decisions taken.

    Used by:
    Legal, compliance and data-protection leads
    Supports:
    Accountability, consistent advice and regulator-ready records
    View typical structure

    Representative IG-Smart structure — client information not shown

    1. 01Matter raised
    2. 02Applicable requirement
    3. 03Advice and options
    4. 04Decision owner
    5. 05Follow-up
  • Understand residual risk

    Board assurance summary · Board, committee or executive reporting

    An executive-level view of material findings, residual risk and decisions requiring accountable-owner attention.

    Used by:
    Boards, Audit Committees, accountable executives
    Supports:
    Risk acceptance, remediation prioritisation and assurance decisions
    View typical structure

    Representative IG-Smart structure — client information not shown

    1. 01Assurance question
    2. 02Evidence reviewed
    3. 03Assurance opinion basis
    4. 04Exceptions and risk acceptance
    5. 05Decisions requested

Differentiation

Why organisations appoint IG-Smart

Each reason links to published cases that show it in practice.

  1. Senior practitioner-led

    Engagements are led by experienced practitioners with direct involvement in substantive advisory and assurance work, supported proportionately where appropriate.

  2. Independent challenge

    Advice and assurance driven by evidence, requirements and risk rather than incentives to sell a technology platform.

  3. Practical, decision-ready outputs

    Work designed to support accountable owners, procurement teams, executives and boards.

    Evidenced by
  4. Experience in regulated and high-consequence environments

    Evidence supported through the published portfolio.

  5. Retained capability where continuity matters

    Evidence from managed and long-term client relationships.

Confidentiality & controlled disclosure

Evidence without compromising client confidentiality

Some of IG-Smart's most sensitive engagements involve regulatory, operational, security, commercial or patient-safety information that cannot responsibly be published in full. Where necessary, examples are anonymised or withheld from public listing.

Additional evidence may sometimes be available, subject to:

  • Confidentiality
  • Client permissions
  • Appropriateness for the buyer
  • Procurement stage
  • IG-Smart approval

Need evidence relevant to your requirement?

Tell us the sector, service or procurement requirement you are assessing.